Dr. Aleksandra Majchrzak-Celińska works at the Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences (PUMS), Poland. She completed her Ph.D. studies at PUMS in 2009. The aim of her Ph.D. thesis was the evaluation of the DNA methylation profile of genes selected on the basis of their diagnostic and/or prognostic potential in central nervous system tumors. Her habilitation focused on the canonical Wnt pathway as a therapeutic target and as a source of biomarkers for the diagnosis of brain tumors. Currently, she works as an associate professor and co-supervises Ph.D. theses regarding the use of selected nanoformulations in the treatment of glioblastoma.
Research Keywords & Expertise
Biomarkers
Brain Tumors
Epigenetics
glioblastoma
Pharmacoepigenetics
Phytocompounds
Wnt/β-catenin pathway
Fingerprints
43%
glioblastoma
28%
Epigenetics
25%
Biomarkers
19%
Brain Tumors
10%
Wnt/β-catenin pathway
7%
Pharmacoepigenetics
5%
Phytocompounds
Short Biography
Dr. Aleksandra Majchrzak-Celińska works at the Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences (PUMS), Poland. She completed her Ph.D. studies at PUMS in 2009. The aim of her Ph.D. thesis was the evaluation of the DNA methylation profile of genes selected on the basis of their diagnostic and/or prognostic potential in central nervous system tumors. Her habilitation focused on the canonical Wnt pathway as a therapeutic target and as a source of biomarkers for the diagnosis of brain tumors. Currently, she works as an associate professor and co-supervises Ph.D. theses regarding the use of selected nanoformulations in the treatment of glioblastoma.
Well done!
